Alterations to the nitric oxide pathway in the spontaneously hypertensive rat
Authors:
- Eduardo NavaEduardo Nava
- Antonio L. FarréAFAntonio L. Farré
- Carol MorenoCMCarol Moreno
- Santos CasadoSCSantos Casado
- Pierre MoreauPMPierre Moreau
- Francesco CosentinoFCFrancesco Cosentino
- Thomas F. LüscherTLThomas F. Lüscher
- 1 May 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 16 (5) , 609-615
Abstract
To examine the role of nitric oxide in the cardiovascular system in spontaneous hypertension. In particular, we wanted to know whether the production of nitric oxide in the cardiovascular system of the spontaneously hypertensive rat is different from that of the normotensive Wistar–Kyoto rat and whether nitric oxide is biologically effective in this system. We studied various aspects of the L-arginine–nitric oxide pathway in the cardiovascular system of spontaneously hypertensive rats and Wistar–Kyoto rats. To address the first objective we analysed the expression of endothelial nitric oxide synthase in the heart by Western blotting and the activity of constitutive nitric oxide synthase in resistance microvessels obtained from the mesenterium, both from spontaneously hypertensive rats and Wistar–Kyoto rats aged 14–18 weeks. We also analysed the concentration of the oxidative product of nitric oxide, nitrate, in plasma from these rats. To address the second objective, that is, to assess the bioactivity of nitric oxide, we studied the accumulation in tissue of cyclic guanosine 3′,5′-monophosphate (GMP), as well as the acute and chronic effects of withdrawing the nitric oxide vasodilatory tone with the inhibitor of nitric oxide synthesis N G-nitro-L-arginine methyl ester on Wistar–Kyoto rats and spontaneously hypertensive rats. We found that the expression of endothelial nitric oxide synthase in the heart, the activity of constitutive nitric oxide synthase in resistance microvessels and the concentration of nitrate in plasma were all significantly higher in the spontaneously hypertensive rats. In contrast, neither cyclic GMP levels nor the effects of N G-nitro-L-arginine methyl ester were greater in the spontaneously hypertensive rat than they were in the Wistar–Kyoto rat. The nitric oxide pathway is upregulated in the resistance circulation and the heart of the spontaneously hypertensive rat by a mechanism involving induction of the constitutive nitric oxide synthase and overproduction of nitric oxide. However, nitric oxide is not sufficiently bioactive to stimulate the formation of cyclic GMP and to maintain an adequate nitric oxide-dependent vasodilatory tone. J Hypertens 16:609–615 © 1998 Lippincott-Raven Publishers.Keywords
This publication has 15 references indexed in Scilit:
- Nitric oxide synthase activity in renal cortex and medulla of normotensive and spontaneously hypertensive ratsAmerican Journal of Hypertension, 1996
- Changes in nitric oxide release in vivo in response to vasoactive substancesBritish Journal of Pharmacology, 1996
- Increased Activity of Constitutive Nitric Oxide Synthase in Cardiac Endothelium in Spontaneous HypertensionCirculation, 1995
- Induction of calcium-dependent nitric oxide synthases by sex hormones.Proceedings of the National Academy of Sciences, 1994
- Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression.Circulation Research, 1994
- Release of nitric oxide evoked by nerve stimulation in guinea-pig intestineNeuroscience, 1993
- Induction and potential biological relevance of a Ca2+‐independent nitric oxide synthase in the myocardiumBritish Journal of Pharmacology, 1992
- Structure and function of small arteriesPhysiological Reviews, 1990
- Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat.Hypertension, 1986
- Blood hyperviscosity in spontaneously hypertensive ratsThrombosis Research, 1980